Evidence map›Paper›PMID 28756964›Full record

ArticleInternational journal of medical microbiology : IJMM2017

Key features of invasive pneumococcal isolates recovered in Lima, Peru determined through whole genome sequencing.

Paulina Hawkins, Erik Mercado, Sopio Chochua, Maria E Castillo, Isabel Reyes, Eduardo Chaparro, Rebecca Gladstone, Stephen D Bentley, Robert F Breiman, Benjamin J Metcalf and 3 more

Open access · hybridAbstract read
In one paragraph

Article in International journal of medical microbiology : IJMM, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed, 3 pooled it
0.5field-weighted citation impact, top 32% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 3 syntheses or guidelines pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Pooled it
  4. Article
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors at 5 institutions in 3 countries.

Paulina HawkinsEmory University, Atlanta, USA; Centers for Disease Control and Prevention, Atlanta, USA. Electronic address: pahues@emory.edu.
Erik MercadoUniversidad Peruana Cayetano Heredia, Lima, Peru.
Sopio ChochuaCenters for Disease Control and Prevention, Atlanta, USA.
Maria E CastilloUniversidad Peruana Cayetano Heredia, Lima, Peru; Instituto Nacional de Salud del Niño, Lima, Peru.
Isabel ReyesHospital de Emergencias Pediátricas, Lima, Peru.
Eduardo ChaparroUniversidad Peruana Cayetano Heredia, Lima, Peru; Hospital Cayetano Heredia, Lima, Peru.
Rebecca GladstoneWellcome Trust Sanger Institute, Cambridge, UK.
Stephen D BentleyWellcome Trust Sanger Institute, Cambridge, UK.
Robert F BreimanEmory University, Atlanta, USA.
Benjamin J MetcalfCenters for Disease Control and Prevention, Atlanta, USA.
Bernard BeallCenters for Disease Control and Prevention, Atlanta, USA.
Theresa J OchoaUniversidad Peruana Cayetano Heredia, Lima, Peru.
Lesley McGeeCenters for Disease Control and Prevention, Atlanta, USA.
Centers for Disease Control and Prevention · USUniversidad Peruana Cayetano Heredia · PEEmory University · USWellcome Sanger Institute · GBHospital Nacional Cayetano Heredia · PE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Before PCV7 introduction, invasive pneumococcal disease (IPD) was responsible for approximately 12,000-18,000 deaths annually among children <5years in Latin America. In Peru, PCV7 was introduced in 2009. We used whole genome sequencing to deduce key features of invasive strains collected in Lima, Peru from 2006 to 2011. We sequenced 212 IPD isolates from 16 hospitals in Lima pre (2006-2009; n=133) and post (2010-2011; n=79) PCV7 introduction; 130 (61.3%) isolates were from children≤5years old. CDC's Streptococcus lab bioinformatics pipeline revealed serotypes, sequence types (STs), pilus genes, PBP types and other resistance determinants. During the pre-PCV7 period, serotype 14 was the most common serotype (24.8%), followed by 6B (20.3%), 19F (10.5%), and 23F (6.8%). Post-PCV7, the proportion of PCV7 serotype 6B decreased significantly (to 6.3%), while 19F (16.3%), 14 (15.0%), 23F (7.5%), and 19A (7.5%) were the most common serotypes; only serotypes 3 and 10A increased significantly. Overall, 82% (n=173) of all isolates carried at least one resistance determinant, including 72 (34%) isolates that carried resistance determinants against 3 or more antimicrobial classes; of these 72 isolates, 56 (78%) belonged to a PCV7 serotype. Eighty-two STs were identified, with 53 of them organized in 14 clonal complexes. ST frequencies were distributed differently pre and post-PCV7 introduction, with only 18 of the 57 STs identified in years 2006-2009 isolates also observed in years 2010-2011 isolates. The apparent expansion of a 19F/ST1421 lineage with predicted β-lactam resistance (PBP type 13:16:20) and carrying resistance determinants against four additional antimicrobial classes was observed.

Indexed as

Pneumococcal VaccinesWhole Genome SequencingAdultAnti-Infective AgentsChild, PreschoolDrug Resistance, BacterialGenotypeHumansInfantPeruPneumococcal InfectionsSerogroupStreptococcus pneumoniaeVaccines, ConjugateAnti-Infective AgentsPneumococcal VaccinesVaccines, ConjugateAntimicrobial resistanceS. pneumoniaeWhole genome sequencing

Identifiers

PMID28756964
PMCPMC5615106
OpenAlexW2737949946

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.